These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 446009)

  • 21. Mental retardation in Greenland.
    Dyggve H; Kodahl T
    Dan Med Bull; 1971 Dec; 18(6):157-60. PubMed ID: 5136194
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's in a name?
    Windle C
    Monogr Am Assoc Ment Defic (1973); 1973; (1):19-25. PubMed ID: 4806611
    [No Abstract]   [Full Text] [Related]  

  • 24. Disease pattern among 942 mentally retarded persons in a Danish county.
    Dyggve H; Kodahl T
    Acta Psychiatr Scand; 1979 Apr; 59(4):381-94. PubMed ID: 155388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in psychotropic drug use.
    Cooperstock R
    Soc Sci Med (1967); 1978 Jul; 12(3B):179-86. PubMed ID: 725615
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Informed consent for medication in persons with mental retardation and mental illness.
    O'Sullivan JL; Borcherding BG
    Health Matrix Clevel; 2002; 12(1):63-92. PubMed ID: 12013701
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends in the residential (inpatient) treatment of individuals with a dual diagnosis.
    Spreat S; Behar D
    J Consult Clin Psychol; 1994 Feb; 62(1):43-8. PubMed ID: 7913478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
    Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
    Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problem behavior and psychiatric impairment within a developmentally disabled population. II: Behavior severity.
    Jacobson JW
    Appl Res Ment Retard; 1982; 3(4):369-81. PubMed ID: 7168573
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of rationalizing drug treatment of patients with epilepsy and mental retardation.
    Beghi E; Bollini P; Di Mascio R; Cerisola N; Merloni T; Manghi E
    Dev Med Child Neurol; 1987 Jun; 29(3):363-9. PubMed ID: 3596072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sudden death in persons with mental retardation--the questionnaire survey in nationwide residential facilities for intellectual disability].
    Hamaguchi H; Arima M
    No To Hattatsu; 2000 Nov; 32(6):551-2. PubMed ID: 11144174
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic medication for elderly patients: use with caution.
    Ruskin PE; Nyman GW; Krajewski TF
    Md Med J; 1986 Nov; 35(11):939-40. PubMed ID: 3807669
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 39. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mood and anxiety symptoms in an adolescent with Pervasive Developmental Disorder Not Otherwise Specified and moderate mental retardation.
    Williams DT; Hirsch S; Coffey B
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):721-6. PubMed ID: 17979592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.